Aqua Bio Technology ASA (OSL:ABTEC)
Norway · Delayed Price · Currency is NOK 0.7100
+0.0150 (2.16%)
At close: Sep 12, 2025
Aqua Bio Technology ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 100.87 | 106.56 | 18.41 | 7.02 | 1.56 | 0.44 | Upgrade |
Other Revenue | 1.88 | 0.62 | 0.33 | 0.14 | 0.42 | 0.37 | Upgrade |
| 102.75 | 107.17 | 18.74 | 7.16 | 1.98 | 0.81 | Upgrade | |
Revenue Growth (YoY) | 41.52% | 472.00% | 161.63% | 262.49% | 143.11% | -37.26% | Upgrade |
Cost of Revenue | 104.05 | 104.54 | 8.34 | 4.69 | 0.95 | 0.98 | Upgrade |
Gross Profit | -1.3 | 2.63 | 10.4 | 2.47 | 1.02 | -0.17 | Upgrade |
Selling, General & Admin | 109.26 | 113.77 | 36 | 21.52 | 17.79 | 15.82 | Upgrade |
Operating Expenses | 120.64 | 125.51 | 39.68 | 23.18 | 18.88 | 15.94 | Upgrade |
Operating Income | -121.95 | -122.88 | -29.28 | -20.71 | -17.86 | -16.1 | Upgrade |
Interest Expense | -51.96 | -19.01 | -4.49 | -2.24 | -1.46 | -0 | Upgrade |
Interest & Investment Income | 36.13 | 0.3 | 0.06 | 0 | - | 0 | Upgrade |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.31 | -0.15 | 0.2 | -0.06 | Upgrade |
Other Non Operating Income (Expenses) | -0.73 | -0.73 | -0.31 | - | - | 1.21 | Upgrade |
EBT Excluding Unusual Items | -138.52 | -142.33 | -34.34 | -23.1 | -19.11 | -14.95 | Upgrade |
Gain (Loss) on Sale of Assets | -44.71 | -44.71 | - | - | - | - | Upgrade |
Asset Writedown | -163.7 | -163.7 | -0.8 | - | - | - | Upgrade |
Other Unusual Items | 8.52 | 5.57 | 14.3 | 4.34 | - | - | Upgrade |
Pretax Income | -338.41 | -345.17 | -20.85 | -18.75 | -19.11 | -14.95 | Upgrade |
Income Tax Expense | -8.06 | -7.81 | 0.18 | -0.02 | - | -0.25 | Upgrade |
Net Income | -330.35 | -337.35 | -21.02 | -18.74 | -19.11 | -14.7 | Upgrade |
Net Income to Common | -330.35 | -337.35 | -21.02 | -18.74 | -19.11 | -14.7 | Upgrade |
Shares Outstanding (Basic) | 94 | 68 | 31 | 21 | 19 | 16 | Upgrade |
Shares Outstanding (Diluted) | 94 | 68 | 31 | 21 | 19 | 16 | Upgrade |
Shares Change (YoY) | 88.80% | 122.82% | 47.34% | 7.88% | 18.67% | 25.77% | Upgrade |
EPS (Basic) | -3.53 | -4.96 | -0.69 | -0.91 | -0.99 | -0.91 | Upgrade |
EPS (Diluted) | -3.54 | -4.96 | -0.69 | -0.92 | -0.99 | -0.91 | Upgrade |
Free Cash Flow | -10.2 | -47.93 | -19.34 | -15.45 | -20.97 | -13.47 | Upgrade |
Free Cash Flow Per Share | -0.11 | -0.70 | -0.63 | -0.74 | -1.09 | -0.83 | Upgrade |
Gross Margin | -1.27% | 2.45% | 55.51% | 34.52% | 51.82% | -20.78% | Upgrade |
Operating Margin | -118.68% | -114.66% | -156.29% | -289.21% | -903.89% | -1981.81% | Upgrade |
Profit Margin | -321.51% | -314.77% | -112.21% | -261.62% | -967.45% | -1809.43% | Upgrade |
Free Cash Flow Margin | -9.93% | -44.72% | -103.24% | -215.73% | -1061.42% | -1657.67% | Upgrade |
EBITDA | -115.85 | -116.33 | -27.27 | -19.47 | -16.9 | -15.99 | Upgrade |
EBITDA Margin | -112.74% | -108.55% | -145.57% | -271.94% | - | - | Upgrade |
D&A For EBITDA | 6.1 | 6.54 | 2.01 | 1.24 | 0.96 | 0.11 | Upgrade |
EBIT | -121.95 | -122.88 | -29.28 | -20.71 | -17.86 | -16.1 | Upgrade |
EBIT Margin | -118.68% | -114.65% | -156.29% | -289.21% | - | - | Upgrade |
Revenue as Reported | 102.75 | 107.17 | 18.74 | 7.16 | 1.98 | 0.81 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.